CDC Alerts Nation to Prepare for COVID-19 Vaccine by Early November
CDC has notified officials across all 50 states that limited vaccine doses might be available by late October
CDC has notified officials across all 50 states that limited vaccine doses might be available by late October
AZD1222 utilizes a replication-deficient chimpanzee adenovirus to deliver a SARS-CoV-2 protein to induce a protective immune response.
Seroprevalence lower for HCP who reported always wearing a face covering while caring for patients.
SARS-CoV-2 viral RNA detected for a mean of 14.1 days among children who are asymptomatic.
Data, not politics, would guide any FDA decision on vaccines, according to agency commissioner
Previously, the EUA limited use to patients with severe COVID-19 disease.
Reports received by the FDA include hand sanitizer sold in a pouch that resembled a snack.
Likelihood of receiving antibiotics higher for more severe illness, at for-profit hospitals.
The ACIP release guidelines for the 2020-2021 vaccination recommendations; In COVID, there’s developments in convalescent plasma authorization, a 15 minute test, and ethnobotanist’s give a stark warning concerning a plant that some are touting as a cure. In other news an intrauterine device gains expanded approval and there’s a label update for hydrochlorothiazide.
Results are provided within 15 minutes and can be read directly from the testing card.